Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · PROTEAN

PROTEAN

Information TechnologyIT - Services₹2436 cr market cap
₹712.10 ▲ +6.0% today As of 19 Nov 2026
52-week low ₹446.4052-week high ₹868.90

-22.7% from the 52-week high · +50.5% above the low

Protean EGov Technologies Ltd offers digital solutions for government and corporate sectors, including financial services and compliance management. The company integrates technology platforms to simplify processes, enhance transparency, and improve service delivery.

The short version. PROTEAN reported revenue of ₹271 crore for Sep 2026, up 8.4% from a year earlier. Net profit was ₹16 crore (down 33.3% year on year). Return on equity was 9.3% in Mar 2026.

1 · The price

How has the stock traded?

PROTEAN trades 22.7% below its 52-week high and 50.5% above its 52-week low.

Change over period: —

1M+8.8%
3M+23.1%
6M+23.2%
1Y-19.9%

2 · The business

Is it growing?

Sales, year on year+8.4%

Sep 2026 revenue of ₹271 cr.

Profit, year on year-33.3%

Sep 2026 net profit of ₹16 cr.

Net margin6.1%

3.4 pts lower than a year earlier.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue271251308229250211222202
Net profit166302224242023
Net margin %6.12.39.99.89.511.39.211.3
EPS (₹)4.021.447.485.545.885.885.035.66

Annual

FY2026FY2025FY2024
Revenue998841882
Net profit1019297
Net margin %10.111.011.0
EPS (₹)24.7722.824.05

3 · The quality

How well does it turn capital into profit?

Return on equity was 9.3% in Mar 2026; debt to equity is 0.00.

Profitability · 3 years

Returns and margins

Mar 2026Mar 2025Mar 2024
Return on equity %9.39.310.5
Return on capital %11.711.213.5
EBITDA margin %17.216.416.5
Net margin %9.410.210.2

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
Debt to equity0.00
Interest cover20.5x
Current ratio2.00

4 · The owners

Who holds it, and are they adding?

Foreign institutions4.7%

Down 5.21 pts over 8 quarters.

Domestic institutions21.49%

Down 8.6 pts over 8 quarters.

Mutual fund schemes2

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter000000000
FII9.9110.918.797.777.548.616.014.7-5.21
DII30.0927.7924.7421.6821.4621.2521.1521.49-8.6
Public60.061.366.4770.5571.0170.1472.8473.81+13.81

Mutual fund holdings · Oct 2026

2 schemes hold this stock

2 the month before.

  • Mirae Asset BSE Information Technology Index Fund0.18% of NAV
  • NIPPON INDIA SMALL CAP FUND0.12% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for PROTEAN are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about PROTEAN

What is the PROTEAN share price?

PROTEAN (PROTEAN) last closed at ₹712.10, up 6.0% on the day. Its 52-week range is ₹446.40 to ₹868.90.

What is the market cap of PROTEAN?

PROTEAN has a market capitalisation of about ₹2,436 crore.

How are PROTEAN's latest results?

PROTEAN reported revenue of ₹271 crore for Sep 2026, up 8.4% from a year earlier. Net profit was ₹16 crore (down 33.3% year on year). Return on equity was 9.3% in Mar 2026.

Who owns PROTEAN?

As of Sep 2026, shareholding was: FII 4.7%, DII 21.49%, Public 73.81%.

How many mutual funds hold PROTEAN?

2 mutual fund schemes held PROTEAN in October 2026. That compares with 2 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 29 Aug 2025 · Final Dividend - Rs. 10
  • 06 Sep 2024 · Final Dividend - Rs. 10

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.